| |
| |
|
| Insider
Information: |
Glover Steve C |
| Relationship: |
Chief Executive Office... |
| City: |
Davie |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,099,812 |
|
|
Indirect Shares
|
43,847 |
|
|
| Direct
Value |
$9,827,209 |
|
|
|
Indirect Value
|
$26,637 |
|
|
| Total
Shares |
1,143,659 |
|
|
| Total
Value |
$9,853,846 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Auriga Laboratories Inc |
ARGA |
Director |
2006-12-10 |
215,000 |
2006-12-10 |
0 |
Premium* |
|
|
Insmed Inc |
INSM |
President Follow-on Bi... |
2009-03-31 |
372,113 |
2007-06-25 |
0 |
Premium* |
|
|
PDS Biotechnology Corp |
PDSB |
|
2021-06-15 |
63,790 |
2020-02-14 |
0 |
Premium* |
|
|
Zyversa Therapeutics Ord Shs |
ZVSA |
Chief Executive Office... |
2022-12-12 |
448,909 |
2022-12-12 |
43,847 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZVSA |
Zyversa Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2022-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
178,925 |
43,847 |
0 |
- |
|
| ZVSA |
Zyversa Therapeutics Ord ... |
Chief Executive Officer |
• • – |
2022-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
448,909 |
448,909 |
0 |
- |
|
| PDSB |
PDS Biotechnology Corp |
|
• • – |
2021-06-15 |
4 |
B |
$8.50 |
$49,997 |
D/D |
5,882 |
63,790 |
0.01 |
- |
|
| PDSB |
PDS Biotechnology Corp |
|
• • – |
2020-02-14 |
4 |
A |
$1.30 |
$49,920 |
D/D |
38,400 |
57,908 |
0 |
- |
|
| INSM |
Insmed Inc |
President Follow-on Biologics |
• – – |
2009-03-31 |
4 |
D |
$1.00 |
$105,049 |
D/D |
(105,049) |
372,113 |
0 |
- |
|
| INSM |
Insmed Inc |
President Follow-on Biologics |
• – – |
2009-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
108,317 |
477,162 |
0 |
- |
|
| INSM |
Insmed Inc |
President Follow-on Biologics |
• – – |
2009-03-31 |
4 |
D |
$1.00 |
$232,381 |
D/D |
(232,381) |
368,845 |
0 |
- |
|
| INSM |
Insmed Inc |
President Follow-on Biologics |
• – – |
2009-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
232,381 |
601,226 |
0 |
- |
|
| INSM |
Insmed Inc |
President Follow-on Biologics |
• – – |
2008-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
288,845 |
368,845 |
0 |
- |
|
| INSM |
Insmed Inc |
President Follow-on Biologics |
• – – |
2007-06-25 |
4 |
B |
$0.78 |
$62,936 |
D/D |
80,000 |
80,000 |
2.74 |
- |
|
| ARGA |
Auriga Laboratories Inc |
Director |
– • – |
2006-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
215,000 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
